| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.ATV.0000202656.53964.04 |
| P698 | PubMed publication ID | 16397140 |
| P2093 | author name string | Ronald R Bach | |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 456-461 | |
| P577 | publication date | 2006-01-05 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Arteriosclerosis, Thrombosis, and Vascular Biology | Q4797542 |
| P1476 | title | Tissue factor encryption | |
| P478 | volume | 26 |
| Q35866675 | "Gum bug, leave my heart alone!"--epidemiologic and mechanistic evidence linking periodontal infections and atherosclerosis. |
| Q82935283 | Activated protein C modulates inflammation, apoptosis and tissue factor procoagulant activity by regulating endoplasmic reticulum calcium depletion in blood monocytes |
| Q35067413 | Activated protein C up-regulates procoagulant tissue factor activity on endothelial cells by shedding the TFPI Kunitz 1 domain. |
| Q34734159 | Activation of Coagulation by Lenalidomide-Based Regimens for the Treatment of Multiple Myeloma |
| Q39525125 | Activation of coagulation by a thalidomide-based regimen |
| Q50212099 | Aggregation of monocytes and platelets interferes in measurement of monocyte viability with phosphatidylserine expression but not with Mitochondrial membrane potential in whole blood |
| Q35950219 | Airway tissue factor-dependent coagulation activity in response to sulfur mustard analog 2-chloroethyl ethyl sulfide |
| Q33828959 | Analysis of factor VIIa binding to relipidated tissue factor by surface plasmon resonance |
| Q37509347 | Analysis of tissue factor expression in various cell model systems: cryptic vs. active |
| Q28220433 | Anithrombotic prevention in vascular disease: bases for a new strategy in antithrombotic therapy |
| Q38104276 | Association of microparticles and preeclampsia |
| Q30496573 | Binding of anti-GRP78 autoantibodies to cell surface GRP78 increases tissue factor procoagulant activity via the release of calcium from endoplasmic reticulum stores |
| Q43072978 | Bovine protein disulfide isomerase-enhanced tissue factor coagulant function: is phospholipid contaminant in it the real culprit? |
| Q34657739 | Breast cancer phenotypes regulated by tissue factor-factor VII pathway: Possible therapeutic targets |
| Q40098296 | CCAAT/enhancer-binding protein-beta participates in insulin-responsive expression of the factor VII gene |
| Q33563067 | Cell-based evaluation of changes in coagulation activity induced by antineoplastic drugs for the treatment of acute myeloid leukemia |
| Q38752911 | Cell-based laboratory evaluation of coagulation activation by antineoplastic drugs for the treatment of lymphoid tumors |
| Q64093592 | Coagulation Pathways in Neurological Diseases: Multiple Sclerosis |
| Q38081822 | Comparison of natural and recombinant tissue factor proteins: new insights |
| Q45812583 | Contribution of procoagulant phospholipids, thrombomodulin activity and thrombin generation assays as prognostic factors in intensive care patients with septic and non-septic organ failure |
| Q35080581 | Cryptic messages: is noncoagulant tissue factor reserved for cell signaling? |
| Q33887458 | Cystine 186-cystine 209 disulfide bond is not essential for the procoagulant activity of tissue factor or for its de-encryption |
| Q35911478 | Decryption of tissue factor |
| Q47352518 | Dendrimer-Induced Leukocyte Procoagulant Activity Depends on Particle Size and Surface Charge |
| Q39730721 | Development of a continuous assay for the measurement of tissue factor procoagulant activity on intact cells |
| Q35080351 | Disulfide isomerization switches tissue factor from coagulation to cell signaling |
| Q36907376 | Disulfide reduction abolishes tissue factor cofactor function |
| Q41303350 | Dynamical view of membrane binding and complex formation of human factor VIIa and tissue factor |
| Q36071796 | Ectonucleotide Triphosphate Diphosphohydrolase-1 (CD39) Mediates Resistance to Occlusive Arterial Thrombus Formation after Vascular Injury in Mice |
| Q45889137 | Effect of glycoPEGylation on factor VIIa binding and internalization |
| Q38117739 | Encryption and decryption of tissue factor. |
| Q46102720 | Encryption remains cryptic. |
| Q35084705 | Endometriosis and tissue factor |
| Q36744706 | Equine herpesvirus type 1 infection induces procoagulant activity in equine monocytes |
| Q38723998 | Evaluation of procoagulant tissue factor expression in canine hemangiosarcoma cell lines. |
| Q39498553 | Evaluation of tissue factor expression in canine tumor cells |
| Q45863643 | Expression of tissue factor in canine mammary tumours and correlation with grade, stage and markers of haemostasis and inflammation. |
| Q38607382 | Extracellular Thiol Isomerases and Their Role in Thrombus Formation |
| Q34074935 | Extracellular protein disulfide isomerase regulates coagulation on endothelial cells through modulation of phosphatidylserine exposure. |
| Q37187990 | Factor VIIa interaction with tissue factor and endothelial cell protein C receptor on cell surfaces |
| Q38927284 | Factor VIIa-antithrombin complex: a possible new biomarker for activated coagulation. |
| Q34736260 | Fas-induced apoptosis increases hepatocyte tissue factor procoagulant activity in vitro and in vivo. |
| Q40076856 | Fibrin formation by wounded bronchial epithelial cell layers in vitro is essential for normal epithelial repair and independent of plasma proteins |
| Q41893303 | Glycosylation of tissue factor is not essential for its transport or functions |
| Q42575662 | Hemolysis-associated hypercoagulability in sickle cell disease: the plot (and blood) thickens! |
| Q36405104 | Hepatocyte tissue factor contributes to the hypercoagulable state in a mouse model of chronic liver injury |
| Q82906597 | Homocysteine enhances clot-promoting activity of endothelial cells via phosphatidylserine externalization and microparticles formation |
| Q61404383 | Human platelets express endothelial protein C receptor, which can be utilized to enhance localization of factor VIIa activity |
| Q28386730 | Inhibition of phosphoinositol 3 kinase contributes to nanoparticle-mediated exaggeration of endotoxin-induced leukocyte procoagulant activity |
| Q58573275 | Interference With Coagulation Cascade as a Novel Approach to Counteract Cisplatin-Induced Acute Tubular Necrosis; an Experimental Study in Rats |
| Q39474586 | Interferon-γ and tumor necrosis factor-α act synergistically to up-regulate tissue factor in alveolar epithelial cells |
| Q54345990 | LPS from Neisseria meningitidis is crucial for inducing monocyte- and microparticle-associated tissue factor activity but not for tissue factor expression |
| Q37277026 | Loop dynamics of the extracellular domain of human tissue factor and activation of factor VIIa |
| Q41406598 | Low‐carb tissue factor? |
| Q39050585 | Microparticle association and heterogeneity of tumor-derived tissue factor in plasma: is it important for coagulation activation? |
| Q35131040 | Microparticles in hemostasis and thrombosis. |
| Q37109691 | Modulation of tissue factor-factor VIIa signaling by lipid rafts and caveolae |
| Q39313484 | Murine tissue factor coagulant activity is critically dependent on the presence of an intact allosteric disulfide. |
| Q38072904 | New Fundamentals in Hemostasis |
| Q41813517 | P2X7 receptor signaling contributes to tissue factor-dependent thrombosis in mice |
| Q34636901 | PARP-14 combines with tristetraprolin in the selective posttranscriptional control of macrophage tissue factor expression |
| Q37770447 | Pathophysiological role of blood-borne tissue factor: should the old paradigm be revisited? |
| Q38185941 | Pathophysiology of acute coronary syndrome |
| Q92817152 | Phagocytosis by endothelial cells inhibits procoagulant activity of platelets of essential thrombocythemia in vitro |
| Q42563535 | Plasma TF activity predicts cardiovascular mortality in patients with acute myocardial infarction |
| Q37020416 | Plasmin enhances cell surface tissue factor activity in mesothelial and endothelial cells |
| Q35639584 | Posttranslational modifications of tissue factor |
| Q45865116 | Preferential localization of recombinant factor VIIa to platelets activated with a combination of thrombin and a glycoprotein VI receptor agonist |
| Q47641296 | Prognostic implications and procoagulant activity of phosphatidylserine exposure of blood cells and microparticles in patients with atrial fibrillation treated with pulmonary vein isolation |
| Q41975370 | Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation |
| Q37240148 | Protein disulfide isomerase as a trigger for tissue factor-dependent fibrin generation |
| Q36709845 | Rapid activation of monocyte tissue factor by antithymocyte globulin is dependent on complement and protein disulfide isomerase |
| Q36572590 | Regulation of tissue factor coagulant activity on cell surfaces |
| Q46626111 | Response: Cys186-Cys209 disulfide–mutated tissue factor does not equal cryptic tissue factor: no impairment in decryption of disulfide mutated tissue factor |
| Q46415515 | Response: Tissue factor de-encryption: the cell model system. |
| Q38117725 | Revisited role of microparticles in arterial and venous thrombosis. |
| Q33729609 | Role of PDI in regulating tissue factor: FVIIa activity. |
| Q36991834 | Role of tissue factor disulfides and lipid rafts in signaling |
| Q34676688 | Role of tissue factor in thrombosis in antiphospholipid antibody syndrome |
| Q37710137 | S-nitrosothiols as selective antithrombotic agents - possible mechanisms |
| Q34122462 | Soluble guanylate cyclase agonists inhibit expression and procoagulant activity of tissue factor |
| Q27658963 | Spectroscopic Characterization of Successive Phosphorylation of the Tissue Factor Cytoplasmic Region |
| Q88638111 | Sphingomyelin encrypts tissue factor: ATP-induced activation of A-SMase leads to tissue factor decryption and microvesicle shedding |
| Q43964625 | Stimulation of Naïve Monocytes and PBMCs with Coagulation Proteases Results in Thrombin‐Mediated and PAR‐1‐Dependent Cytokine Release and Cell Proliferation in PBMCs Only |
| Q87147177 | Synergies of phosphatidylserine and protein disulfide isomerase in tissue factor activation |
| Q33717037 | Systems biology of coagulation initiation: kinetics of thrombin generation in resting and activated human blood |
| Q36062304 | The Role of Putative Phosphatidylserine-Interactive Residues of Tissue Factor on Its Coagulant Activity at the Cell Surface |
| Q33354913 | The complex puzzle underlying the pathophysiology of acute coronary syndromes: from molecular basis to clinical manifestations |
| Q36710224 | The interface between coagulation and immunity |
| Q37868584 | The missing link between atherosclerosis, inflammation and thrombosis: is it tissue factor? |
| Q37088087 | The prothrombotic activity of cancer cells in the circulation |
| Q37877499 | The role of tissue factor in systemic inflammatory response syndrome |
| Q34765561 | The septic milieu triggers expression of spliced tissue factor mRNA in human platelets. |
| Q37852747 | Therapeutic modulation of coagulation and fibrinolysis in acute lung injury and the acute respiratory distress syndrome |
| Q37903631 | Thiol pathways in the regulation of tissue factor prothrombotic activity |
| Q36579545 | Thioredoxin and Thioredoxin Reductase Control Tissue Factor Activity by Thiol Redox-dependent Mechanism |
| Q28196701 | Thrombin generation by activated factor VII on platelet activated by different agonists. Extending the cell-based model of hemostasis |
| Q35911577 | Tissue Factor encryption and decryption: Facts and controversies |
| Q36360421 | Tissue factor activation: is disulfide bond switching a regulatory mechanism? |
| Q37240167 | Tissue factor activity and function in blood coagulation |
| Q33592102 | Tissue factor and PAR2 signaling in the tumor microenvironment |
| Q34599765 | Tissue factor and tissue factor pathway inhibitor as key regulators of global hemostasis: measurement of their levels in coagulation assays |
| Q45931438 | Tissue factor coagulant function is enhanced by protein-disulfide isomerase independent of oxidoreductase activity. |
| Q37438302 | Tissue factor in coagulation: Which? Where? When? |
| Q42481165 | Tissue factor is unregulated in microvascular endothelial cells of patients with heart failure. |
| Q38017367 | Tissue factor isoforms in cancer and coagulation: may the best isoform win. |
| Q38079283 | Tissue factor non-coagulant signaling - molecular mechanisms and biological consequences with a focus on cell migration and apoptosis. |
| Q33710084 | Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis |
| Q37240160 | Tissue factor storage, synthesis and function in normal and activated human platelets |
| Q37288296 | Tissue factor structure and function |
| Q35850659 | Tissue factor trafficking in fibroblasts: involvement of protease-activated receptor-mediated cell signaling |
| Q35923274 | Tissue factor-dependent and -independent pathways of systemic coagulation activation in acute myeloid leukemia: a single-center cohort study |
| Q38117740 | Tissue factor-integrin interactions in cancer and thrombosis: every Jack has his Jill |
| Q37444639 | Tissue factor: mechanisms of decryption |
| Q64906886 | Tissue factor: newer concepts in thrombosis and its role beyond thrombosis and hemostasis. |
| Q37634815 | Tissue factor: past, present, and future |
| Q35778603 | Tissue factor; from Morawitz to microparticles |
| Q34358144 | Upregulation of the Coagulation Factor VII Gene during Glucose Deprivation Is Mediated by Activating Transcription Factor 4 |
| Q39651171 | Use of immuno-magnetic beads for direct capture of nanosized microparticles from plasma |
Search more.